[go: up one dir, main page]

ME01465B - Sinteza dihidrotieno[3 ,2-d]pirimidin diola i sličnih pirimidin diola - Google Patents

Sinteza dihidrotieno[3 ,2-d]pirimidin diola i sličnih pirimidin diola

Info

Publication number
ME01465B
ME01465B MEP-2012-113A MEP11312A ME01465B ME 01465 B ME01465 B ME 01465B ME P11312 A MEP11312 A ME P11312A ME 01465 B ME01465 B ME 01465B
Authority
ME
Montenegro
Prior art keywords
pyrimidine diols
dihydrothieno
synthesis
diols
similar
Prior art date
Application number
MEP-2012-113A
Other languages
English (en)
Inventor
Rogelio Perez Frutos
Thomas G Tampone
Jason Alan Mulder
Dhileepkumar Krishnamurthy
Chris Hugh Senanayake
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41319263&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01465(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ME01465B publication Critical patent/ME01465B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MEP-2012-113A 2008-05-13 2009-05-07 Sinteza dihidrotieno[3 ,2-d]pirimidin diola i sličnih pirimidin diola ME01465B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5281608P 2008-05-13 2008-05-13
EP09736709A EP2315755B1 (en) 2008-05-13 2009-05-07 SYNTHESIS OF DIHYDROTHIENO[3,2-d]PYRIMIDINE DIOLS AND SIMILAR PYRIMIDINE DIOLS
PCT/US2009/043068 WO2009140127A2 (en) 2008-05-13 2009-05-07 SYNTHESIS OF DIHYDROTHIENO[3,2-d]PYRIMIDINE DIOLS AND SIMILAR PYRIMIDINE DIOLS

Publications (1)

Publication Number Publication Date
ME01465B true ME01465B (me) 2014-04-20

Family

ID=41319263

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2012-113A ME01465B (me) 2008-05-13 2009-05-07 Sinteza dihidrotieno[3 ,2-d]pirimidin diola i sličnih pirimidin diola

Country Status (31)

Country Link
US (1) US8471010B2 (me)
EP (1) EP2315755B1 (me)
JP (1) JP5281153B2 (me)
KR (1) KR20110021764A (me)
CN (1) CN102026984B (me)
AR (1) AR071720A1 (me)
AU (1) AU2009246686B2 (me)
BR (1) BRPI0912546A2 (me)
CA (1) CA2722970A1 (me)
CL (1) CL2009001149A1 (me)
CO (1) CO6260135A2 (me)
CY (1) CY1113577T1 (me)
DK (1) DK2315755T3 (me)
EA (1) EA019735B1 (me)
EC (1) ECSP10010571A (me)
ES (1) ES2392920T3 (me)
HR (1) HRP20120860T1 (me)
IL (1) IL208382A0 (me)
MA (1) MA32312B1 (me)
ME (1) ME01465B (me)
MX (1) MX2010011025A (me)
MY (1) MY152292A (me)
NZ (1) NZ588484A (me)
PL (1) PL2315755T3 (me)
PT (1) PT2315755E (me)
RS (1) RS52476B (me)
SI (1) SI2315755T1 (me)
TW (1) TWI421254B (me)
UA (1) UA99964C2 (me)
WO (1) WO2009140127A2 (me)
ZA (1) ZA201006891B (me)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA08280783B1 (ar) * 2007-01-11 2011-04-24 استرازينيكا ايه بي مشتقات بيريدوبيريميدين كمثبطات pde4
US9173884B2 (en) 2011-11-30 2015-11-03 Trustees Of Boston College Inhibitors of phosphodiesterase 11 (PDE11)
WO2025131986A1 (en) 2023-12-19 2025-06-26 Boehringer Ingelheim International Gmbh Novel synthetic steps for the manufacturing method of the pde4b-inhibitor 1-({(5r)-2-[4-(5-chloropyrimidine-2-yl)piperidine-1-yl]-5-oxido-6,7-dihydrothieno[3,2-d]pyrimidine-4-yl}amino)cyclobutyl]methanol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470336A1 (de) * 1962-07-04 1969-03-20 Thomae Gmbh Dr K Neue Dihydrothieno-[3,4-d]-pyrimidine und Verfahren zu ihrer Herstellung
FR2029250A5 (me) * 1969-01-21 1970-10-16 Roussel Uclaf
TW200410975A (en) * 2002-09-26 2004-07-01 Nihon Nohyaku Co Ltd New pesticide and method for using it, new substituted thienopyrimidine derivative, its intermediate, and method for producing it
EP1874781B9 (de) * 2006-04-19 2010-09-08 Boehringer Ingelheim International GmbH Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
US7851468B2 (en) * 2006-05-15 2010-12-14 Cephalon, Inc. Substituted pyrazolo[3,4-d]pyrimidines

Also Published As

Publication number Publication date
CY1113577T1 (el) 2016-06-22
IL208382A0 (en) 2010-12-30
WO2009140127A3 (en) 2010-01-28
ZA201006891B (en) 2011-06-29
CL2009001149A1 (es) 2010-07-23
PT2315755E (pt) 2012-10-03
JP5281153B2 (ja) 2013-09-04
AU2009246686B2 (en) 2014-02-13
TWI421254B (zh) 2014-01-01
EA201001775A1 (ru) 2011-06-30
UA99964C2 (en) 2012-10-25
AU2009246686A1 (en) 2009-11-19
BRPI0912546A2 (pt) 2016-10-18
KR20110021764A (ko) 2011-03-04
JP2011520886A (ja) 2011-07-21
HRP20120860T1 (hr) 2012-11-30
MY152292A (en) 2014-09-15
EA019735B1 (ru) 2014-05-30
ECSP10010571A (es) 2010-11-30
DK2315755T3 (da) 2012-10-15
AR071720A1 (es) 2010-07-07
SI2315755T1 (sl) 2012-10-30
MX2010011025A (es) 2010-11-05
HK1151524A1 (en) 2012-02-03
CO6260135A2 (es) 2011-03-22
WO2009140127A2 (en) 2009-11-19
MA32312B1 (fr) 2011-05-02
US20110130563A1 (en) 2011-06-02
ES2392920T3 (es) 2012-12-17
CN102026984B (zh) 2013-12-25
EP2315755A2 (en) 2011-05-04
EP2315755B1 (en) 2012-08-08
RS52476B (sr) 2013-02-28
US8471010B2 (en) 2013-06-25
NZ588484A (en) 2012-06-29
TW201006841A (en) 2010-02-16
CA2722970A1 (en) 2009-11-19
CN102026984A (zh) 2011-04-20
PL2315755T3 (pl) 2013-01-31

Similar Documents

Publication Publication Date Title
IL204854A0 (en) Preparation of dihydrothieno [3, 2 - d] pyrimidines and intermediates used therein
ZA201102885B (en) Configuration and tracking of 2-d modular heliostat
EP2335659A4 (en) URINE COLLECTOR AND ARTICLE TO BE CARRYED
IL216609A0 (en) Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
IL232382A (en) History of Foro [3, 2 – d] Pyrimidine, preparations containing them and their use in the preparation of drugs
ZA201308527B (en) Forms of rifaximin and uses thereof
EP2379443A4 (en) NANOSTRUCTURED ARTICLES AND METHOD FOR PRODUCING NANOSTRUCTURED ARTICLES
ZA200809967B (en) Thieno[3,2-D] pyrimidine derivative useful as PI3K inhibitor
ME01558B (me) TIENO [2, 3-B] PIRIDINDION AMPK AKTIVATORI l NJIHOVE TERAPEUTSKE UPOTREBE
EP2170764A4 (en) METHOD FOR PRODUCING HIERARCHIC ARTICLES
EP2227540A4 (en) DIFFERENTIATION OF HUMAN CELLS
EP2069477A4 (en) CHEMICAL REPULSION OF CELLS
IL219935A0 (en) Small pyrimidine derivatives and methods of use thereof
IL208382A0 (en) Synthesis of dihydrothieno[3,2-d]pyrimidine diols and similar pyrimidine diols
IL203537A0 (en) Novel polygalacturonases and their uses
PL2349663T3 (pl) Wytłaczane jednowarstwowe płyty wiórowe i sposoby ich wytwarzania
ZA200807853B (en) Modulair continuous production of micro-organisms
GB0807073D0 (en) Methods and manufacture of extended area articles
IL207848A0 (en) Artificial enzymes
ZA201105528B (en) 2-morpholino-pyrido[3,2-d]pyrimidines
ZA201000371B (en) Article of jewelerry
HK1150609A (en) Forms of rifaximin and uses thereof
AU2006904986A0 (en) Article of clothing
GB0815555D0 (en) Big ass knickers & pocket
PL2024372T3 (pl) Pochodna tieno[3,2-D]pirymidyny użyteczna jako inibitor PI3K